-
Astria Therapeutics Announces Publication of Navenibart Phase 1a Healthy Subject Results in the Annals of Allergy, Asthma & Immunology
01 May 2025 12:32 GMT
… , and effective attack prevention for hereditary angioedema (HAE) with dosing every 3 … development for the treatment of hereditary angioedema. Our second program, STAR-0310 …
-
Sustained Efficacy of Donidalorsen Every 8 Weeks in Hereditary Angioedema
11 Apr 2025 19:08 GMT
… 8 Weeks in Patients With Hereditary Angioedema: Two-Year Update,” published in …
-
Hereditary angioedema attacks fall 62% with switch to donidalorsen
10 Apr 2025 13:45 GMT
… 93%.
SAN DIEGO — Patients with hereditary angioedema who switched from other drugs … 16 of donidalorsen treatment. Mean Hereditary Angioedema Control Test (AECT) scores improved …
-
KalVista Pharmaceuticals enrols all subjects in hereditary angioedema drug trial
26 Mar 2025 19:59 GMT
… kallikrein inhibitor designed to treat hereditary angioedema (HAE) in children.
This open …
-
Hereditary Angioedema Patients Face High Rates of Autoimmune Conditions, Allergies
22 Mar 2025 20:46 GMT
… study, participants with hereditary angioedema reported a greater prevalence … University in Hamilton, Canada.
Hereditary angioedema (HAE), a rare, potentially … Comorbidities in Canadian patients with hereditary angioedema: a quantitative survey study. …
-
On-demand sebetralstat effective for hereditary angioedema attacks in larynx
19 Mar 2025 21:23 GMT
… to Healio
1.9% of hereditary angioedema attacks involved the larynx, which … sebetralstat.
SAN DIEGO — Patients with hereditary angioedema whose attacks impacted their larynx … than 50% of patients with hereditary angioedema (HAE) experience an attack that …
-
Indirect Comparison of Oral Sebetralstat and Intravenous rhC1INH for Hereditary Angioedema
18 Mar 2025 07:19 GMT
… for on-demand treatment of hereditary angioedema attacks,” published in the March … al.
On-demand treatment for hereditary angioedema aims to stop attack progression …
-
Astria Therapeutics to Present at Upcoming Citizens Life Sciences Conference
30 Apr 2025 12:20 GMT
… development for the treatment of hereditary angioedema. Our second program, STAR-0310 …
-
Ionis reports first quarter 2025 financial results
30 Apr 2025 11:11 GMT
… independent launch for donidalorsen in hereditary angioedema and Phase 3 results for … prophylactic treatment for people with hereditary angioedema (HAE), assuming approval:
Under review …
-
Dong-A ST profit soars as Stelara biosimilar launch drives Q1 gains at Dong-A Socio
30 Apr 2025 11:50 GMT
… decision in August for a hereditary angioedema therapy using ST Pharm’s …